Moody's assigns 'A3' rating to Fred Hutchinson Cancer Research Center's bonds

Moody's Investors Service assigned an "A3" rating to Seattle-based Fred Hutchinson Cancer Research Center's proposed bonds, including:

  • $19 million of series 2017A revenue bonds
  • $86 million of series 2017C revenue bonds

The rating affirmations are based on a number of factors, including the cancer center's national standing as a leading research institute, strong unrestricted liquidity and strong fundraising capabilities.

The outlook is stable, reflecting Moody's Investors Service's expectation the cancer center will improve its liquidity supporting debt and operations, its growing research activity and positive operating cash flow generation for adequate debt service.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars